Ownership history in Eversept Partners, LP · 15 quarters on record
This page tracks every 13F SEC filing in which Eversept Partners, LP reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,782,235 | -142,071 | -7.4% | 2.79% | $55.5M | $31.12 |
| 2025 Q3 | ADDED | 1,924,306 | +21,767 | +1.1% | 2.86% | $41.5M | $21.58 |
| 2025 Q2 | ADDED | 1,902,539 | +524,865 | +38.1% | 2.45% | $26.6M | $13.98 |
| 2025 Q1 | ADDED | 1,377,674 | +597,676 | +76.6% | 1.89% | $18.6M | $13.48 |
| 2024 Q4 | ADDED | 779,998 | +88,766 | +12.8% | 1.33% | $15.0M | $19.17 |
| 2024 Q3 | ADDED | 691,232 | +123,745 | +21.8% | 1.08% | $15.7M | $22.75 |
| 2024 Q2 | ADDED | 567,487 | +425,412 | +299.4% | 0.51% | $7.4M | $13.01 |
| 2024 Q1 | ADDED | 142,075 | +4,732 | +3.4% | 0.17% | $2.5M | $17.51 |
| 2023 Q4 | REDUCED | 137,343 | -305,927 | -69.0% | 0.26% | $3.0M | $21.78 |
| 2023 Q3 | REDUCED | 443,270 | -35,117 | -7.3% | 0.58% | $6.8M | $15.34 |
As of 2025 Q4 — sorted by position size